1. From the Institut National de la Santé et de la Recherche Médicale (INSERM) U503, Faculté Laennec, F-69372 Lyon Cedex 08, France; INSERM U404, F-69365 Lyon Cedex 07, France; the Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, France; the Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada; and the Department of Clinical Immunology, Centre Hospitalier Lyon-Sud, F-69495